A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT06557148
- Status
- Recruiting
Conditions
- Breast Cancer
- Breast Carcinoma
- Lobular Breast Carcinoma
- Metastatic Breast Cancer
- Metastatic Breast Carcinoma
- Metastatic Lobular Breast Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 18F-Fluoroestradiol PET/CT — DIAGNOSTIC_TESTScanned at baseline and again posttreatment within 2 weeks of the restaging FDG PET/CT
Study Details
The purpose of this study to compare two types of cancer imaging scans to see which is better at detecting and monitoring metastatic ILC. This study will compare PET/CT (positron emission tomography/computed tomography) scans using the radiotracer fluorine 18 (18F)-fluoroestradiol (FES) with a standard imaging approach for detecting and monitoring ILC, PET/CT scans using the radiotracer 18F-fluorodeoxyglucose (FDG). These scans will be referred to as FES PET/CT scans and FDG PET/CT scans.
Key Dates
- Start date
- Aug 13, 2024
- Status verified
- Feb 2026
- Primary completion
- Aug 13, 2027
- Completion
- Aug 13, 2027
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: Biopsy-proven ER+ Metastatic Invasive Lobular Carcinoma/ILCParticipants will have biopsy-proven metastatic ILC, confirmed ER+ breast cancer
Primary Outcome Measure
Comparison of FES PET/CT in Metastatic Invasive Lobular Carcinoma/ILC to standard-of-care (SOC) imaging with FDG PET/CT at baseline [ Time Frame: 1 year ]
Central Contacts
- Somali Gavane, MD212-639-2403
- Komal Jhaveri, MD646-888-5145
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | Somali Gavane, MD 212-639-2403 |
| Memorial Sloan Kettering Monmouth (Limited protocol activities) | Middletown | New Jersey | 07748 | Somali Gavane, MD 212-639-2403 |
| Memorial Sloan Kettering Bergen (All Protocol Activities) | Montvale | New Jersey | 07645 | Somali Gavane, MD 212-639-2403 |
| Memorial Sloan Kettering Suffolk-Commack (All protocol activity) | Commack | New York | 11725 | Somali Gavane, MD 212-639-2403 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | Somali Gavane, MD 212-639-2403 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | Somali Gavane, MD 212-639-2403 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activites) | Rockville Centre | New York | 11553 | Somali Gavane, MD 212-639-2403 |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited protocol activities)· Middletown, NJMemorial Sloan Kettering Bergen (All Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk-Commack (All protocol activity)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)· New York, NY
Related Studies
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey